Anthony Petrone
Stock Analyst at Mizuho
(4.04)
# 523
Out of 4,670 analysts
160
Total ratings
50%
Success rate
12.14%
Average return
Main Sectors:
Stocks Rated by Anthony Petrone
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HOLX Hologic | Maintains: Outperform | $90 → $87 | $78.97 | +10.17% | 8 | Nov 5, 2024 | |
| TFX Teleflex | Maintains: Neutral | $275 → $250 | $191.71 | +30.41% | 7 | Nov 1, 2024 | |
| LIVN LivaNova | Maintains: Outperform | $80 → $70 | $51.32 | +36.40% | 7 | Oct 31, 2024 | |
| BSX Boston Scientific | Maintains: Outperform | $100 → $110 | $90.00 | +22.22% | 8 | Oct 24, 2024 | |
| ABT Abbott Laboratories | Maintains: Neutral | $115 → $130 | $117.76 | +10.39% | 4 | Oct 17, 2024 | |
| ADMA ADMA Biologics | Maintains: Buy | $12 → $14 | $21.18 | -33.90% | 6 | Jun 20, 2024 | |
| ESTA Establishment Labs Holdings | Maintains: Buy | $65 → $70 | $43.08 | +62.49% | 6 | Jun 6, 2024 | |
| ALC Alcon | Maintains: Buy | $100 → $105 | $85.99 | +22.11% | 8 | May 15, 2024 | |
| STAA STAAR Surgical Company | Maintains: Buy | $53 → $55 | $26.68 | +106.15% | 7 | May 8, 2024 | |
| LNTH Lantheus Holdings | Maintains: Buy | $90 → $100 | $90.52 | +10.47% | 5 | May 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $110 → $105 | $82.44 | +27.37% | 6 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $20 → $16 | $4.52 | +253.98% | 3 | Apr 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $85 → $100 | $144.00 | -30.56% | 6 | Apr 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $95 → $105 | $70.48 | +48.98% | 7 | Apr 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $215 | $243.78 | -11.81% | 15 | Mar 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $250 | $188.73 | +32.46% | 6 | Mar 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $44 | $48.24 | -8.79% | 1 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $14 | $9.20 | +52.17% | 4 | Mar 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $103 → $115 | $100.80 | +14.09% | 14 | Mar 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $95 → $98 | $86.21 | +13.68% | 4 | Feb 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $350 → $390 | $547.87 | -28.82% | 6 | Jan 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $63 → $67 | $107.97 | -37.95% | 2 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $110 → $115 | $85.55 | +34.42% | 14 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $200 → $175 | $110.22 | +58.77% | 3 | Nov 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $30 → $25 | $16.64 | +50.24% | 3 | May 13, 2020 |
Hologic
Nov 5, 2024
Maintains: Outperform
Price Target: $90 → $87
Current: $78.97
Upside: +10.17%
Teleflex
Nov 1, 2024
Maintains: Neutral
Price Target: $275 → $250
Current: $191.71
Upside: +30.41%
LivaNova
Oct 31, 2024
Maintains: Outperform
Price Target: $80 → $70
Current: $51.32
Upside: +36.40%
Boston Scientific
Oct 24, 2024
Maintains: Outperform
Price Target: $100 → $110
Current: $90.00
Upside: +22.22%
Abbott Laboratories
Oct 17, 2024
Maintains: Neutral
Price Target: $115 → $130
Current: $117.76
Upside: +10.39%
ADMA Biologics
Jun 20, 2024
Maintains: Buy
Price Target: $12 → $14
Current: $21.18
Upside: -33.90%
Establishment Labs Holdings
Jun 6, 2024
Maintains: Buy
Price Target: $65 → $70
Current: $43.08
Upside: +62.49%
Alcon
May 15, 2024
Maintains: Buy
Price Target: $100 → $105
Current: $85.99
Upside: +22.11%
STAAR Surgical Company
May 8, 2024
Maintains: Buy
Price Target: $53 → $55
Current: $26.68
Upside: +106.15%
Lantheus Holdings
May 3, 2024
Maintains: Buy
Price Target: $90 → $100
Current: $90.52
Upside: +10.47%
May 1, 2024
Maintains: Buy
Price Target: $110 → $105
Current: $82.44
Upside: +27.37%
Apr 11, 2024
Maintains: Neutral
Price Target: $20 → $16
Current: $4.52
Upside: +253.98%
Apr 11, 2024
Maintains: Neutral
Price Target: $85 → $100
Current: $144.00
Upside: -30.56%
Apr 11, 2024
Maintains: Buy
Price Target: $95 → $105
Current: $70.48
Upside: +48.98%
Mar 27, 2024
Maintains: Buy
Price Target: $215
Current: $243.78
Upside: -11.81%
Mar 27, 2024
Maintains: Buy
Price Target: $250
Current: $188.73
Upside: +32.46%
Mar 6, 2024
Maintains: Buy
Price Target: $30 → $44
Current: $48.24
Upside: -8.79%
Mar 1, 2024
Maintains: Buy
Price Target: $13 → $14
Current: $9.20
Upside: +52.17%
Mar 1, 2024
Maintains: Buy
Price Target: $103 → $115
Current: $100.80
Upside: +14.09%
Feb 21, 2024
Maintains: Buy
Price Target: $95 → $98
Current: $86.21
Upside: +13.68%
Jan 25, 2024
Maintains: Neutral
Price Target: $350 → $390
Current: $547.87
Upside: -28.82%
Aug 3, 2023
Downgrades: Hold
Price Target: $63 → $67
Current: $107.97
Upside: -37.95%
Feb 8, 2023
Maintains: Buy
Price Target: $110 → $115
Current: $85.55
Upside: +34.42%
Nov 5, 2021
Maintains: Buy
Price Target: $200 → $175
Current: $110.22
Upside: +58.77%
May 13, 2020
Maintains: Hold
Price Target: $30 → $25
Current: $16.64
Upside: +50.24%